Trimedyne Inc.: The Irvine company’s stock rose...
- Share via
Trimedyne Inc.: The Irvine company’s stock rose 20% Wednesday after Trimedyne said it received a patent covering the use of laser devices for various procedures, including treating enlarged prostates. The laser can also be used to cut, shape and shrink tissues of other organs and of tumors. Trimedyne stock closed at $3, up 50 cents, in Nasdaq trading.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
